Diagnostics World News | Emerging approaches to the early detection of cancer were highlighted during the recent Next Generation Dx Summit held in Washington, D.C. Representatives from diagnostics companies Oxomics, Elypta, Micronoma, and Rivela Diagnostics took turns making their case for a new generation of technologies hunting for elusive molecular signatures of a highly heterogenous group of diseases.
Sep 22, 2022